Antibiotice S.A.'s latest marketcap:
As of 07/04/2025, Antibiotice S.A.'s market capitalization has reached $371.95 M. According to our data, Antibiotice S.A. is the 16191th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 371.95 M |
| Revenue (ttm) | 154.85 M |
| Net Income (ttm) | 22.66 M |
| Shares Out | 671.34 M |
| EPS (ttm) | 0.03 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 09/25/2025 |
| Earnings Date | 08/14/2025 |
Antibiotice S.A.'s yearly market capitalization.
| Date | Market Cap(RON) | Change (%) | Global Rank |
|---|---|---|---|
| 07/04/2025 | 371.95 M | -3.32% | 16191 |
| 12/30/2024 | 1.72 B | 83.51% | 15234 |
| 12/29/2023 | 936.52 M | 146.47% | 18607 |
| 12/30/2022 | 379.98 M | -6.6% | 23576 |
| 12/30/2021 | 406.83 M | 24.69% | 23571 |
| 12/30/2020 | 326.27 M | -4.33% | 21763 |
| 12/30/2019 | 341.04 M | 4.31% | 19310 |
| 12/31/2018 | 326.94 M | -9.48% | 18393 |
| 12/29/2017 | 361.18 M | 3.46% | 18410 |
| 12/30/2016 | 349.1 M | -2.26% | 16955 |
Company Profile
About Antibiotice S.A.
Antibiotice S.A. is a leading Romanian pharmaceutical company specializing in the production and sale of medicinal products. Established in 1955 and headquartered in Iasi, Romania, the company serves both domestic and international markets.
Product Portfolio
Antibiotice S.A. develops and manufactures medicines across a broad spectrum of therapeutic areas, including:
- Cardiovascular system
- Alimentary tract and metabolism
- Musculo-skeletal system
- Nervous system
- Antiinfectives
- Respiratory system
- Dermatological
- Food supplements
- Sensory organs
- Genito-urinary apparatus and sexual hormones
- Blood and blood-forming organs
- Veterinary medicinal products
Product Forms
The company offers its products in various formulations, such as:
- Sterile injectable powders
- Capsules and tablets
- Ointments, gels, and creams
- Suppositories
Additional Offerings
Beyond finished pharmaceutical products, Antibiotice S.A. also supplies active pharmaceutical ingredients (APIs) and exports its products worldwide.
Frequently Asked Questions
-
What is Antibiotice S.A.'s (BVB-ATB) current market cap?As of 07/04/2025, Antibiotice S.A. (including the parent company, if applicable) has an estimated market capitalization of $371.95 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Antibiotice S.A. (BVB-ATB) rank globally by market cap?Antibiotice S.A. global market capitalization ranking is approximately 16191 as of 07/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.